Michael F. Holick, MD, PhD, the Boston University professor of medicine and well-known “apostle of vitamin D,” attracted a standing-room-only crowd Friday for a presentation on his favorite topic. It was a performance that had the audience at rapt attention for a full hour-not just because of the celebrity of the speaker, but because of the extraordinarily clever and engaging nature of his presentation.

Early in his keynote address, James Orbinski, MD, Senior Fellow at the University of Toronto and one of the world’s leading scholars and scientists in global health, complimented the United States on the recent passage of its health care bill, a “seminal achievement” that he said brought the US “just a hair’s breadth away” from achieving universal health care.

Probiotics and prebiotics are now widely used by patients – and even present in many common foods.

How will your practice manage the coming “tsunami” of older patients as the baby boomers enter their golden years?

Like other complex chronic diseases, diabetes is difficult to manage effectively in one-to-one visits in the office setting, said Edward Shahady, MD.

One of your patients is a 30-year-old woman whose BMI is 42. She has been treated for a compulsive eating disorder for the past 10 years, but medications and psychotherapy have not been effective.

To help busy primary care clinicians sort through the many offerings at the American Academy of Family Physicians Scientific Assembly this year, the editors of Consultant have prepared a short list of courses that are sure to please.

Optimal care for patients, greater satisfaction for staff, reliable payment for you … it sounds as if there’s no place like the patient-centered medical home.

2009 IHC Podcasts

Migraine and chronic daily headache may be risk factors for the development of complex regional pain syndrome, according to the results of a study led by B. Lee Peterlin, DO, assistant professor of neurology, Drexel University College of Medicine in Philadelphia.

Results of a large survey show that many patients with cluster headaches (CH) are not receiving treatment with acute and preventive therapies.

The risk of ischemic stroke may be twice as high in patients who experience migraine with aura as in those who have migraine without aura, according to results of a systematic review and meta-analysis.

Did Pablo Picasso suffer from migraine? And did these episodes influence his artwork? Not likely, said Joost Haan, MD, PhD, a member of the department of neurology at Leiden University Medical Centre, Leiden, the Netherlands. He discussed migraine and the works of master painters at the 14th annual International Headache Congress in Philadelphia.

Results of a landmark study showed that onabotulinumtoxinA effectively reduced headache symptoms, episodes, disability, and health-related quality of life in patients with chronic migraine.

Patients with migraine are more likely than nonmigraineurs to experience cardiovascular events, according to recent results of the American Migraine Prevalence and Prevention Study.

Patients with migraine accompanied by depression or anxiety disorders had greater improvements in headache-related disability than those without a psychiatric disorder, according to results of the Treatment of Severe Migraine trial.

About 20% of soldiers returning from Iraq and Afghanistan who have a history of concussion or blast exposure experience chronic daily headache, according to a results of study presented at the 14th annual International Headache Congress in Philadelphia.

Tonabersat is effective in the prophylaxis of aura in patients with migraine, according to a recent study led by Jes Olesen, MD, a professor of neurology at the Danish Headache Center at Glostrup Hospital, University of Copenhagen, Glostrup, Denmark.

Patients with migraine are more likely than nonmigraineurs to have temporomandibular disorder (TMD). According to the results of a new study presented at the 14th annual International Headache Conference in Philadelphia, TMD may also be associated with increased headache frequency.

What is the prognosis for patients with frontotemporal dementia and motor neuron disease? A new study suggests the answer depends not on which occurs first, but whether cognitive and motor symptoms develop simultaneously.